President welcome message

We are honored to welcome you to the MENA Hematology Congress 2025, taking place in Al Madinah, Saudi Arabia, from 13 to 15 November 2025, at Le Méridien Medina. This landmark event brings together leading hematology experts, researchers, clinicians, and healthcare professionals from the Middle East, North Africa, and around the world. The congress serves as a key platform for exploring cutting-edge innovations, exchanging knowledge, and fostering regional and international collaboration in the field of hematology. Our comprehensive scientific program will address a broad spectrum of topics, including: Blood disorders, Hematologic malignancies, Stem cell transplantation, and Emerging therapeutic approaches.
Attendees will meet with more than 100 speakers from around the world, benefit from 31 sessions, 5 meet-the-expert sessions, and panel discussions, all designed to enhance clinical practices and inspire forward-thinking. More than 100 research abstracts will be displayed during the congress. Building on our past successes, three congresses and seven forums—which have included over 32,000 attendees from 52 countries, 600+ distinguished speakers, and 500+ abstracts published in indexed journals—the MENA Hematology Achievement Forum continues to thrive as a premier gathering in the region. This year, in collaboration with the Saudi Society of Periodontology and Implant Dentistry (SSPI), we will host three sessions on dental hematology, specifically designed for dentists and hematologists. It is our pleasure, in collaboration with AlMadinah Hereditary Blood Disorders Association, to host the 5th Saudi Hereditary Blood Disorders Association Conference In addition to groundbreaking research and real-world clinical cases, the congress offers exceptional networking opportunities, helping you engage with peers, collaborators, and global leaders in hematology.

We look forward to welcoming you to an inspiring and impactful congress in the holy city of Madinah.

MD, President, MENA Hematology League Team Leader

Dr. Sarah Sewaralthahab, MD, MPH

MENA Hematology Congress Chair

Pediatric hematology oncology consultant
President congress

MD, President, MENA Hematology League
Team Leader 

MD, President, HEMNET

welcome Message

We are honored to welcome you to the MENA Hematology Congress 2025, taking place in Al Madinah, Saudi Arabia, from 13 to 15 November 2025, at Le Méridien Medina. This landmark event brings together leading hematology experts, researchers, clinicians, and healthcare professionals from the Middle East, North Africa, and around the world. The congress serves as a key platform for exploring cutting-edge innovations, exchanging knowledge, and fostering regional and international collaboration in the field of hematology. Our comprehensive scientific program will address a broad spectrum of topics, including: Blood disorders, Hematologic malignancies, Stem cell transplantation, and Emerging therapeutic approaches.
Attendees will meet with more than 100 speakers from around the world, benefit from 31 sessions, 5 meet-the-expert sessions, and panel discussions, all designed to enhance clinical practices and inspire forward-thinking. More than 100 research abstracts will be displayed during the congress. Building on our past successes, three congresses and seven forums—which have included over 32,000 attendees from 52 countries, 600+ distinguished speakers, and 500+ abstracts published in indexed journals—the MENA Hematology Achievement Forum continues to thrive as a premier gathering in the region. This year, in collaboration with the Saudi Society of Periodontology and Implant Dentistry (SSPI), we will host three sessions on dental hematology, specifically designed for dentists and hematologists. It is our pleasure, in collaboration with AlMadinah Hereditary Blood Disorders Association, to host the 5th Saudi Hereditary Blood Disorders Association Conference In addition to groundbreaking research and real-world clinical cases, the congress offers exceptional networking opportunities, helping you engage with peers, collaborators, and global leaders in hematology.

We look forward to welcoming you to an inspiring and impactful congress in the holy city of Madinah.

welcome Message

The MENA Hematology Congress is an annual event that focuses on the latest advances and breakthroughs in the field of hematology. The congress brings together hematologists, researchers, clinicians, and other healthcare professionals from the Middle East and North Africa region to share their expertise, knowledge, and experience. The congress usually covers a wide range of topics related to hematology, including blood disorders, hematologic malignancies, stem cell transplantation, and other related fields. It provides a platform for researchers and clinicians to present their latest research findings, clinical studies, and case reports. In addition to the scientific sessions, the MENA Hematology Congress also includes keynote speeches, workshops, and panel discussions on various topics related to hematology. The congress provides a unique opportunity for attendees to network with their peers, exchange ideas, and collaborate on future research projects. Overall, the MENA Hematology Congress is a must-attend event for anyone interested in the latest developments in hematology and related fields. It provides a platform for sharing knowledge and expertise, promoting collaboration, and advancing the field of hematology in the Middle East and North Africa region.

Pediatric hematology oncology consultant
Al aziziyah children hospital

Aim

The aim of the congress is to provide attendees with the latest updates in hematology research, diagnosis, and treatment, and to enhance their knowledge and skills in the field. The congress also aims to raise awareness about the latest developments in the field of hematology and to foster collaboration and partnerships among healthcare professionals in the region

Objectives

The objectives of the MENA Hematology Congress are

Thank you to those who submitted abstracts. All abstracts are under review.

We received over 100 abstracts from +20 countries.

Speakers

Scientific program 

Satellite Symposium (Madinah HBD Association)

Chairperson: Dr. Mohamad Zolali

08:00 – 08:40

Prof. Flora Peyvandi 🇮🇹

Rare Bleeding Disorders Then & Now

08:00 – 08:40

Prof. Flora Peyvandi 🇮🇹

Von Willebrand Disease: Diagnosis and Management Updates

Session 111

Bleeding Disorders

  • Chairperson: Dr. Mohamad Zolali  – 🇸🇦
  • Chairperson: Dr. Asem AlAmri  – 🇸🇦

Session 121

Acute Leukemia

  • Chairpersons: Ensherah Barnawi 🇸🇦
  • Chairpersons: Turky Wasidy 🇸🇦

08:00 – 08:20

Dr. Hanan AlKhaldi 🇸🇦

Novel approaches & Targeted therapy in Acute Myeloid Leukemia

08:20 – 08:40

Dr. Eman AboDallah 🇱🇧

Non-chemotherapy Approaches in Philadelphia Positive Acute Lymphoid Leukemia: Is the time right?

08:40 – 09:00

Dr. Mansour AlFayez 🇸🇦

How I treat secondary acute myeloid leukemia

Oral Abstracts / Dental Hematology

Session 131

Oral Abstracts (1): Best Eleven Abstracts

  • Chairpersons: Prof. Galilah Moktar 🇪🇬
  • Chairpersons: Dr. Muneer AlBagshi 🇸🇦

08:15 – 08:30

Dr. Alaa Hamad 🇸🇦

Abstract 11: Predictors of Discordant End-of-Treatment PET Positivity in Advanced-Stage Classical Hodgkin Lymphoma Patients with Negative Interim PET Response

08:30 – 08:15

Dr. Mansoor Neelum 🇵🇰

Abstract 10: Cytogenetic findings and post induction MRD in B-Lymphoblastic Leukemia

08:30 – 08:45

Dr. Maram Aljohani 🇸🇦

Abstract 8: Unraveling the Prognostic Impact of CDKN2A/2B Gene Deletion in Children Diagnosed with Acute Lymphoblastic Leukemia, In Saudi Arabia , A Multicenter Study

Early Career Hematology

09:00 – 10:00

Meet the expert Challenging in Lymphoma (Ticketed session)

Prof. Andrew Davies 🇬🇧

Dr. Alfadel Alshaibani 🇸🇦

10:30 – 11:15

MENA HEMATOLOGY CONGRESS 2025

OPENING CERMONY

11:30 – 12:30

Meet the expert How to conduct and design a research study (Ticketed session)

Prof. Flora Peyvandi 🇮🇹

Prof. Tarek Owaida 🇸🇦

13:00 – 14:00

MENA Board of Director Assembly

Poster Abstracts

08:00 – 12:00

Dr. Ahmed Embaby 🇸🇦

SCREEN 1 Diffuse Large B-Cell Lymphoma Development Post-COVID-19 Vaccination in a Sickle Cell Patient: A Complex Clinical Scenario

08:00 – 12:00

Dr. Mohammed Saeed 🇸🇦

SCREEN 2 Predictors of choices for place of death for Saudi patients with incurable cancer from King Abdul-Aziz Medical City, Riyadh, Saudi Arabia

08:00 – 12:00

Dr. Ahmed Badheeb 🇸🇦

SCREEN 3 Clinical and Therapeutic Profile of Non-Hodgkin's Lymphoma: A Retrospective Study From a Najran Oncology Center

08:00 – 12:00

Dr. Salma Hassan 🇪🇬

SCREEN 4 Telomere Length and response to imatinib therapy in newly diagnosed Chronic Myeloid Leukemia patients-Chronic phase: Measured by Flow-FISH technique

09:00 – 11:00

TimeTopicSpeaker
09:00 – 9:05IntroductionDr. Hany Al Hashmi
09:05 – 9:20Opening Remarks Saudi Hemophilia LandscapeDr. Ashraf Warsi
09:20 – 09:40Hemophilia unmet needsDr. Sarah Sewaralthab
09:40 – 10:10Marstacimab New Era in Hemophilia ManagementDr. Guy Young
10:10 – 10:25From Clinical Trial to Real world experienceDr. Yasser Wail
10:25 – 10:45The Transition: the Omani ExperienceDr. Murtada AL Khaburi

11:00 – 13:00

Jomaa Prayer

13:00 – 13:30

Lunch

Session 211

MENA-HL / Saudi Society of Hematology Joint Symposium Platelet Disorders

  • Chairperson: Prof. Soaad AlJaouni 🇸🇦
  •  Chairperson: Prof.  Tamer Hassan 🇪🇬

Session 221

Prophetic Medicine

  • Chairperson: Prof. Soaad AlJaouni 🇸🇦
  • Chairperson: Dr. Raed Basry 🇸🇦

9:00 – 9:25

Dr. Hassan Chamsi-Pasha 🇸🇦

Horizons of Prophetic Guidance: A Health Perspective

9:25 – 09:50

Dr. SaLah AlSayed 🇸🇦

The role of Cupping Therapy in Thalassemia disorder for precision medicine

9:50 – 10:20

Prof. Soad Al Jaouni 🇸🇦

Prophetic And Precision Medicine in the Spotlight: Global Research Trends And Scientific Breakthroughs

Oral Abstracts / Dental Hematology

Session 231

Dental for Hematologists

  • Chairpersons: Dr. Hani Fadel 🇸🇦
  • Chairpersons: Dr. Shaimaa Bahammam 🇸🇦

09:00 – 09:25

Dr. Hani T Fadel 🇸🇦

Hemoglobinopathies: Dental Perspective

09:25 – 09:50

Dr. Adnan Almaghlouth 🇸🇦

Why Dental Clearance before Hematologic Treatment Matters

09:50 – 10:15

Dr. Hani Salam 🇸🇦

Managing Dental Surgeries in Patients with Coagulopathies: What We Need from Hematologists

Abstracts / Resources Hematology

Session 241

Oral Abstracts (3): Hemophilia

Chairpersons:

  • Dr. Amal Bihan (KSA)
  • Dr. Faisal AlGamdi (KSA)

09:00 – 09:15

Dr. Sanjeev Khera 🇮🇳

Real World Data Of Emicizumab Prophylaxis In Young Children With Severe Hemophilia A Without Inhibitors

09:15 – 09:30

Dr. Muhammad Faisal Khanani 🇦🇪

Treatment Patterns and Clinical Outcomes Following Transition to Efanesoctocog Alfa in Paediatric Haemophilia A: A UAE Single-Centre Study

09:30 – 09:45

Dr. Somayyeh Fahiminiya 🇨🇦

Unraveling novel complex genomic rearrangements in severe hemophilia A patients using optical genome mapping

Early Career Hematology

10:00 – 10:45

Meeting of Saudi Hematology Societies

14:00 – 15:00

Meeting of Saudi Council of Hereditary Blood Disorders Associations

15:00 – 16:00

Meeting of Madinah Hereditary Blood Disorders Association Board

Poster Abstracts

08:00 – 12:00

Dr. Rehab AL-Ansari 🇸🇦

SCREEN 1 Epidemiology of Vascular Thrombosis in the Eastern Province of Saudi Arabia: A Single Center Study and Comparison with National Data

08:00 – 12:00

Dr. Mohamed Safa 🇸🇦

SCREEN 2 Brain Iron Accumulation With Neurodegeneration

08:00 – 12:00

Dr. Abdulaziz Aljohani 🇸🇦

SCREEN 3 CLPB-Related 3-Methylglutaconic Aciduria Type VII : A Crucial Consideration In Severe Congenital Neutropenia with Epilepsy , Case Report

08:00 – 12:00

Dr. abdulrahman al raizah 🇸🇦

SCREEN 4 A Quality Initiative to Improve IVC Filter Use and Retrieval: Translating Guidelines into Practice

08:00 – 08:20

Dr. Sarah Sewaralthahab 🇸🇦

Quality Improvement in Sickle Cell Disease

08:20 – 08:40

All-Comers Treatment Option : Repurposing RBC Energetics Across the Spectrum of Thalassemia

Speaker:Dr. Ali Taher

Session 311

MENA-HL / ESHR Joint Symposium Sickle Cell Disease

  • Chairpersons: Prof. Amal Bishlawi 🇪🇬
  • Chairpersons: Dr. Sarah Sewaralthahab 🇸🇦

08:40 – 09:00

Dr. Saif Elislam 🇸🇦

Modern Approaches to Managing Acute Vaso-Occlusive Crises

Session 321

Happen in Hematology with light grey background

Chairpersons:   Sabri Kemahli 🇹🇷

08:00 – 08:20

Prof. Abeer Abd Elmoneim 🇸🇦

Modifiable risks of pediatric cancer

08:20 – 08:40

Prof. Murtadha Al-Kabori 🇴🇲

Acquired Bleeding Disorders in Malignancy

08:40 – 09:00

Sabri Kamili 🇹🇷

Hematology Education and Training

5th Saudi Forum of Hereditary Blood Diseases Associations

Session-1 (331)

Me and My Illness – Towards a Better Life

  • Chairperson: Dr. Mohammed Al-Shahrani 🇸🇦
  • Chairperson: Mr. Othman Barnawi 🇸🇦

08:00 – 08:45

Commitment to treatment Iron pumps Follow-up on Hydroxyurea

Dr. Islam El-Hawary  🇪🇬
Dr. Mona Hamdy 🇪🇬
Dr. Marwa Zakaria 🇰🇼

 

Session 2 (332)

Associations and Health Services – Our Vision for the Future

Chairpersons::

  • Eng. Ahmed Al-Harthi
  • Mr. Yasser Hawsawi
  • Ms. Aisha Qader
  • Session Supervisor: Prof. Ahmed Tarawah

08:45 – 09:30

Mr. Ahmed Al-Ahmadi
Al-Madinah Association

Mr. Khaled Al-Dhibyan
Jazan Association

Dr. Mohammed Al-Shahrani
Riyadh Association

Dr. Mohammed Darwish
Qatif Association

  Prof. Hatoon Izzat – Director, Blood Disorders Division, Ministry of Health SaudiArabia 🇸🇦

·       Dr. Ahmed Khalifa – Director of “Mohja” Initiative Saudi Arabia 🇸🇦

·       Mr. Ahmed Al-Ahmadi 🇸🇦

·       Mr. Khaled Al-Dhibyan🇸🇦

·       Dr. Mohammed Al-Shahrani🇸🇦

·       Dr. Mohammed Darwish 🇸🇦

Abstracts / Resources Hematology

Session 341

Oral Abstracts (5)

  • Chairpersons: Prof. Galila Moktar 🇪🇬
  • Chairpersons: Prof. Faisal Algamdi 🇸🇦

08:15 – 08:30

Dr. Faisal Al-Harbi 🇸🇦

Impact of Cytoreductive Nephrectomy on Outcomes in Metastatic Renal Cell Carcinoma Patients with Concurrent Hematological Malignancies Receiving Immune Checkpoint Inhibitor Therapy: A Multi-Institutional Retrospective Cohort Analysis

08:30 – 08:45

Dr. Sara Mostafa 🇪🇬

Clinical Spectrum Of An Egyptian Cohort Of Children With Myelodysplastic Syndrome

08:45 – 09:00

Dr. HASIB TK 🇮🇳

Evaluation of TP53 Expression in pediatric B- Cell Acute Lymphoblastic Leukemia and Its Correlation with Clinicopathological Profiles

Early Career Hematology

08:00 – 08:30

MENA Hematology Congress 2025 / 2026 joined meeting

08:30 – 09:00

MENA Hematology Congress 2026 meeting

09:00 – 10:00

Meet the expert

Challenging in Thrombosis

(Ticketed session)

Dr. Ashraf Warsi 🇸🇦

Dr. Sarah Sewaralthahab 🇸🇦

10:00 – 11:00

Meet the expert

Hematology fellowship exam, tricks & pitfalls

(Ticketed session)

Dr. Fawaz AlKasim 🇸🇦

Dr. Ashraf Warsi 🇸🇦

Poster Abstracts

08:00 – 12:00

Dr. Samar Elfiky 🇪🇬

SCREEN 1 Netrin-1 and Clusterin: Valuable Markers for Early Detection of Kidney Injury in Children with Transfusion-Dependent Thalassemia

08:00 – 12:00

Dr. Ahmad Darwish 🇪🇬

SCREEN 2 Investigating the role of B-cell activating factor (BAFF) in multi-transfused children with thalassemia

08:00 – 12:00

Dr. Ruqaiya Al Ghazali 🇴🇲

SCREEN 3 Clinical and Laboratory Outcomes of First and Second Episodes of COVID-19 in Patients with Sickle Cell Disease: A Retrospective Comparative Cohort Study

08:00 – 12:00

Dr. Sajidah Alalwan 🇸🇦

SCREEN 4 The Role of Platelet-to-Neutrophil Ratio (PNR) as a Biomarker for Pulmonary Hypertension and Echocardiographic Changes in Sickle Cell Disease Patients: A Retrospective Cohort Study

Our Sponsors

Strategic

Platinum

Gold

Silver

Bronze

Our Partners

Tickets

The Congress Organizers & all Attendees must follow the SCFHS rules and regulation for CME acquisitions
Upon registering for the conference, you will be granted membership in the association.

Physicians
Physical Attendance 

.
250

Non Physicians 
Physical Attendance

.
200

Medical
Fellows / residents

CME credits are not applicable
150

The abstract  deadline has been extended to August 15th.

Target Audience

The target audience for the MENA Hematology Congress includes

REACH US Get Direction to the Event Hall

Contact Us
1

🎯 Target Audience

  • Dental Public Health
  • General Dentistry
  • Oral and Maxillofacial
  • Surgery
  • Pediatric Dentistry
  • Dental Implant
  • Oral Medicine
  • Preventive Dentistry
  • Dental
  • Dental Hygiene
  • Oral
  • Histology
  • Family Dentistry
  • Geriatric Dentistry
  • Nursing
  • Genetics ‐ Cytogenetics
  • Hematology ‐ Histocompatibility
  • Laboratory ‐ Molecular Genetics
  • Laboratory ‐Transfusion & Blood Bank
  • Laboratory ‐ Cytopathology
  • Laboratory ‐ Clinical Immunology
  • Laboratory ‐ Hematology
  • Laboratory ‐ Genetics
  • Laboratory ‐ Clinical Biochemistry
  • Laboratory ‐ Histopathology Clinical Immunology ‐ Histocompatibility
  • Radiological Technology ‐ Ultrasound
  • Radiological Technology ‐ Magnetic Resonance
  • Technology
  • Radiotherapy
  • Nuclear Medicine
  • Medical Physics ‐ Radiation Protection
  • Medical Physics ‐ Radiotherapy
  • Medical Physics ‐ Medical Nuclear Physics
  • Cardiovascular Technology
  • Biology ( Genomic & Biotechnology )
  • Genetic engineering
  • Phlebotomy
  • Stem Cell Technology
  • Neurophysiology
  • Infection Control, Blood
  • Transfusion Medicine
  • Infectious Disease
  • Hematology
  • Medical Oncology
  • Family Medicine
  • General surgery
  • Pediatrics
  • Internal Medicine
  • Anatomic Pathology
  • Emergency Medicine
  • Obstetrics and Gynecology
  • Vascular Surgery
  • General Practice
  • Neurology
  • Thoracic and Cardiac Surgery
  • Cardiac Surgery
  • Anesthesia
  • Medical Genetics
  • Clinical Pathology
  • Critical Care Medicine
  • Physical Medicine and Rehabilitation
  • Radiation Oncology
  • Diagnostic Radiology
  • Allergy and Immunology
  • Cardiology
  • Public Health
  • Geriatric Medicine
  • Gastroenterology
  • Neuropathology
  • Occupational Medicine
  • Hematological Pathology
  • Pediatric Surgery
  • Thoracic Surgery
  • Neonatal Intensive Care
  • Pediatric Oncology
  • Endocrinology
  • Vascular and Endovascular Surgery
  • Pediatric Complex Care ‐Palliative Care
  • Neonatology
  • Pediatric Emergency Medicine
  • Trauma
  • Developmental Pediatrics
  • Epidemiology
  • Preventive Medicine
  • Pathology
  • Family and Community Medicine
  • Nursing
  • Adult Critical Care Nursing
  • Medical and Surgical Nursing
  • Pain Management Nursing
  • Cardiovascular Nursing
  • Pediatric Nursing
  • Anesthesia Nursing
  • Oncology and Palliative Care Nursing
  • Geriatric Nursing
  • Critical Care
  • Neonatal Critical Care Nursing
  • Emergency Care
  • Wound Care Nursing
  • Community and Public Health Nursing
  • Disaster and Emergency Nursing
  • Pre / Intra / Postoperative Nursing Care
  • Neurophysiology Nursing
  • Pharmaceutical Sciences
  • Clinical Pharmacy
  • Pharmaceutical Administration and Outcomes
  • Pharmacy
  • Physiotherapy Cardiovascular
  • Physiotherapy Geriatrics
  • Physiotherapy Pediatrics
  • Emergency Medical Services
  • Emergency

SOON